How does FDA regulate advertising and labeling of OTC products differently from prescription drugs?

• A. OTC labeling follows 21 CFR Part 201; prescription drugs follow stricter labeling under 21 CFR Part 201 with specific safety information.
• B. OTC labeling follows OTC monographs or labeling standards; prescription drugs follow stricter labeling under 21 CFR Part 201 with specific safety information.
• C. There is no difference; both use the same labeling standards.
• D. OTC labeling has no safety information requirements.

Answer: (B)

OTC labeling is standardized through OTC drug monographs or established labeling standards, which provide a uniform framework for what must be included and how it’s presented. This leads to a common Drug Facts panel across many products, with sections like active ingredients, uses, warnings, directions, and other information. Prescription drugs, by contrast, require FDA-approved, product-specific labeling under 21 CFR Part 201. That labeling reflects the exact safety data from the approved NDA and includes detailed, tailored warnings, contraindications, adverse reactions, dosing, and population considerations. Because Rx products carry higher potential risks, the labeling is stricter and specific to each approved product. This difference is why the statement describing monograph-based labeling for OTCs versus Part 201, NDA-specific labeling for Rx drugs best fits how the FDA regulates them.